RIGL

RIGL R&D Expense Growth

42.41%Fiscal year

Period ending:

RIGL FY R&D Growth (YoY)%
RIGL FY R&D Growth (YoY)104.78%-76.90%
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

RIGL r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
42.408%
-4.657%
-59.3144%
-7.6107%
8.5456%
13.6447%
12.754%
1.3702%
-27.0734%
0.9885%
-7.1954%
-10.1317%
-4.3794%
13.5948%
7.6997%
-29.0392%
-17.2581%
55.861%
23.515%
9.4738%
7.244%
11.8995%
0.03%
34.1565%
0.8709%
87.202%
0%

Compare r&d expense growth

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.